Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia

32Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Clonal haematopoiesis (CH) in patients with acute myeloid leukaemia (AML) may persist beyond attaining complete remission. From a consecutive cohort of 67 patients with nucleophosmin 1-mutated (NPM1mut) AML, we identified 50 who achieved NPM1mut clearance and had parallel multicolour flow cytometry (MFC) and next generation sequencing (NGS). In total, 13 (26%) cleared all mutations, 37 (74%) had persistent CH frequently involving DNA methyltransferase 3α (DNMT3A,70%), tet methylcytosine dioxygenase 2 (TET2, 27%), isocitrate dehydrogenase 2 (IDH2, 19%) and IDH1 (11%). A small number (<1%) of aberrant CD34+ myeloblasts, but immunophenotypically different from original AML blasts [herein referred to as a pre-leukaemic (PL) phenotype], was detected in 17 (49%) patients with CH, but not in any patients with complete clearance of all mutations (P = 0·0037). A PL phenotype was associated with higher mutation burden (P = 0·005). Persistent IDH2 and serine and arginine-rich splicing factor 2 (SRSF2) mutations were exclusively observed in PL+ CH+ cases (P = 0·016). Persistent dysplasia was seen exclusively in cases with a PL+ phenotype (29% vs. none; P = 0·04). The PL+ phenotype did not correlate with age, intensity of induction therapy or relapse-free survival. Post-remission CH in the setting of NPM1mut clearance is common and may result in immunophenotypic changes in myeloid progenitors. It is important to not misinterpret these cells as AML measurable residual disease (MRD).

Author supplied keywords

References Powered by Scopus

Age-related clonal hematopoiesis associated with adverse outcomes

3461Citations
N/AReaders
Get full text

Maftools: Efficient and comprehensive analysis of somatic variants in cancer

2896Citations
N/AReaders
Get full text

Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

1671Citations
N/AReaders
Get full text

Cited by Powered by Scopus

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

431Citations
N/AReaders
Get full text

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

52Citations
N/AReaders
Get full text

Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients

31Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Loghavi, S., DiNardo, C. D., Furudate, K., Takahashi, K., Tanaka, T., Short, N. J., … Wang, S. A. (2021). Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia. British Journal of Haematology, 192(6), 1054–1063. https://doi.org/10.1111/bjh.17347

Readers over time

‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

Researcher 7

44%

PhD / Post grad / Masters / Doc 6

38%

Professor / Associate Prof. 2

13%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 14

64%

Biochemistry, Genetics and Molecular Bi... 7

32%

Engineering 1

5%

Save time finding and organizing research with Mendeley

Sign up for free
0